| 摘要 |
The purpose of the present invention is to provide a novel medicament for the treatment of cancer. The present invention relates to a pharmaceutical composition for the treatment or prophylaxis of cancer, which contains a triethylene glycol represented by formula (I) or a derivative thereof as an active ingredient. (In the formula, each of R1 and R2 is independently selected from among a hydrogen atom, C1-6 alkyl groups, C1-6 haloalkyl groups and -C(=O)R3 groups; and R3 is selected from among C1-6 alkyl groups or C1-6 haloalkyl groups.) |
